{"transactions":[{"id":784611,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (Common Stock)","published_at":"2026-05-11T20:16:00.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":6922870,"price":5.64,"value":39044986.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-26-001346","document":"es260777872_4-matrix.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000095014226001346/es260777872_4-matrix.xml","form_type":"4"}},{"id":969513,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-15T22:24:17.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":7500000,"price":1.33,"value":9975000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6459973,"source":{"system":"sec-edgar","filing":"0000902664-25-005288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000090266425005288/ownership.xml","form_type":"4"}},{"id":1134827,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2025-05-23T20:23:20.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9334735,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among Alumis Inc., a Delaware corporation (\"Alumis\") and ACELYRIN, Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto, each share of Common Stock was cancelled and converted into the right to receive 0.4274 shares of Common Stock, without interest and, if applicable, cash in lieu of fractional shares, subject to any applicable withholding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among Alumis Inc., a Delaware corporation (\"Alumis\") and ACELYRIN, Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto, each share of Common Stock was cancelled and converted into the right to receive 0.4274 shares of Common Stock, without interest and, if applicable, cash in lieu of fractional shares, subject to any applicable withholding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein were held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000902664-25-002533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1548144/000090266425002533/ownership.xml","form_type":"4"}},{"id":1135525,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-05-23T20:20:51.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":4493741,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among ACELYRIN, Inc., a Delaware corporation (\"ACELYRIN\") and Alumis Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto (the \"Merger Agreement\"), the shares of Common Stock were issued to the AyurMaya Fund (as defined below) in exchange for 9,334,735 shares of ACELYRIN common stock on the effective date of the merger contemplated by the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the estimated number of shares of Common Stock to be issued to the AyurMaya Fund (as defined below) pursuant to the Merger Agreement. The Reporting Persons will file an amendment to this Form 4 to the extent the actual number of shares of Common Stock issued differs in any material respect from the number reported in column (4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, as amended on April 20, 2025, by and among ACELYRIN, Inc., a Delaware corporation (\"ACELYRIN\") and Alumis Inc., a Delaware corporation (the \"Issuer\") and the other parties thereto (the \"Merger Agreement\"), the shares of Common Stock were issued to the AyurMaya Fund (as defined below) in exchange for 9,334,735 shares of ACELYRIN common stock on the effective date of the merger contemplated by the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any."}],"balance_after":15139707,"source":{"system":"sec-edgar","filing":"0000902664-25-002532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266425002532/ownership.xml","form_type":"4"}},{"id":1460219,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2024-07-03T20:45:38.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":12745916,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2726398},"source":{"system":"sec-edgar","filing":"0000902664-24-004603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266424004603/ownership.xml","form_type":"4"}},{"id":1460218,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series B-2 Redeemable Convertible Preferred Stock","published_at":"2024-07-03T20:45:38.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":5336489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1141494},"source":{"system":"sec-edgar","filing":"0000902664-24-004603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266424004603/ownership.xml","form_type":"4"}},{"id":1460217,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2024-07-03T20:45:38.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":20000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4278074},"source":{"system":"sec-edgar","filing":"0000902664-24-004603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266424004603/ownership.xml","form_type":"4"}},{"id":1460216,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-03T20:45:38.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":2500000,"price":16,"value":40000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":10645966,"source":{"system":"sec-edgar","filing":"0000902664-24-004603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266424004603/ownership.xml","form_type":"4"}},{"id":1460215,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-07-03T20:45:38.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":8145966,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the \"Common Stock\") (the \"IPO\"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":8145966,"source":{"system":"sec-edgar","filing":"0000902664-24-004603","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000090266424004603/ownership.xml","form_type":"4"}},{"id":1745635,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (Common Stock)","published_at":"2023-11-09T21:35:45.000Z","date":"2023-11-09","kind":"purchase","planned":false,"acquired":true,"shares":1560000,"price":9,"value":14040000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6922870,"source":{"system":"sec-edgar","filing":"0000902664-23-005429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266423005429/ownership.xml","form_type":"4"}},{"id":1849629,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-06-20T20:30:54.000Z","date":"2023-06-20","kind":"purchase","planned":false,"acquired":true,"shares":4760000,"price":22.66,"value":107861600.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":13959973,"source":{"system":"sec-edgar","filing":"0000902664-23-003642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000090266423003642/ownership.xml","form_type":"4"}},{"id":1896418,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2023-05-11T20:10:16.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":3709429,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3709429},"source":{"system":"sec-edgar","filing":"0000902664-23-002975","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1548144/000090266423002975/ownership.xml","form_type":"4"}},{"id":1896417,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2023-05-11T20:10:16.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":5625306,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5625306},"source":{"system":"sec-edgar","filing":"0000902664-23-002975","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1548144/000090266423002975/ownership.xml","form_type":"4"}},{"id":1896416,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":79316,"kind":"person","name":"AyurMaya Capital Management Company, LP","position":1,"cik":"0001975990","reported_name":"AyurMaya Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2023-05-11T20:10:16.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":true,"shares":9334735,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock is convertible into one share of Common and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of Common Stock (the \"IPO\"), all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held by AyurMaya Capital Management Fund, LP (the \"AyurMaya Fund\"). AyurMaya Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":9334735,"source":{"system":"sec-edgar","filing":"0000902664-23-002975","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1548144/000090266423002975/ownership.xml","form_type":"4"}},{"id":2093194,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2022-12-07T21:30:57.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":1250000,"price":12,"value":15000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":5362870,"source":{"system":"sec-edgar","filing":"0000902664-22-005061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266422005061/ownership.xml","form_type":"4"}},{"id":2524434,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":2327870,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2327870},"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2524433,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"purchase","acquired":true,"shares":1785000,"price":14,"value":24990000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":4112870,"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2524432,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (\"Common Stock\")","published_at":"2021-11-04T20:44:54.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":2327870,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock was convertible at any time, at the holder's election on a 1-for-1 basis, and did not have an expiration date. The shares of Series E Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":2327870,"source":{"system":"sec-edgar","filing":"0000902664-21-004738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000090266421004738/ownership.xml","form_type":"4"}},{"id":2796903,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":30268,"price":42.3769,"value":1282664.0092,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.01 to $42.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12309090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796902,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":25732,"price":41.4673,"value":1067036.5636,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41 to $42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12339358,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796901,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":34302,"price":41.1605,"value":1411887.471,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.005 to $41.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12365090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796900,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":215698,"price":40.4238,"value":8719332.8124,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40 to $41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12399392,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796899,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":85911,"price":41.6216,"value":3575753.2776,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.495, to $41.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12615090,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796898,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":71194,"price":41.2063,"value":2933641.3222,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.49 to $41.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12701001,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796897,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":33600,"price":39.9714,"value":1343039.04,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.845 to $40.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12772195,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796896,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":75000,"price":39.2155,"value":2941162.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.83 to $39.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12805795,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2796895,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-11T00:45:24.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":234295,"price":38.2181,"value":8954309.7395,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.8275 to $38.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the\n \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the\n Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":12880795,"source":{"system":"sec-edgar","filing":"0000902664-21-001835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001835/ownership.xml","form_type":"4"}},{"id":2854470,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T02:40:28.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":3759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein."}],"balance_after":3759,"derivative":{"exercise_price":66.5,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":3759},"source":{"system":"sec-edgar","filing":"0000902664-21-001476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001476/ownership.xml","form_type":"4"}},{"id":2854469,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T02:40:28.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0000902664-21-001476","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266421001476/ownership.xml","form_type":"4"}},{"id":3077712,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:15:48.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":2000000,"price":40,"value":80000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":13115090,"source":{"system":"sec-edgar","filing":"0000902664-20-002761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266420002761/ownership.xml","form_type":"4"}},{"id":3154356,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-11T20:15:31.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein."}],"balance_after":8888,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0000902664-20-002039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266420002039/ownership.xml","form_type":"4"}},{"id":3300102,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-28T21:15:37.000Z","date":"2020-01-24","kind":"exercise","acquired":false,"shares":2217101,"price":26.5,"value":58753176.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":15115090,"source":{"system":"sec-edgar","filing":"0000902664-20-000523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266420000523/ownership.xml","form_type":"4"}},{"id":3471250,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series F-1 Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":84359,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":10.6686,"underlying":"Common Stock","underlying_shares":84359},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471249,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":11154116,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":8.9653,"underlying":"Common Stock","underlying_shares":11154116},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471248,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series E-1 Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":5893716,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":6.0389,"underlying":"Common Stock","underlying_shares":5893716},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471247,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471246,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":84359,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":17332191,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471245,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":11154116,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":17247832,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471244,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":5893716,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":6093716,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3471243,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":2,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-02T21:53:56.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000902664-19-002915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000090266419002915/ownership.xml","form_type":"4"}},{"id":3940167,"issuer":{"id":1363,"kind":"organization","name":"POPULAR, INC.","symbol":"BPOP"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Par Value $0.01 per share","published_at":"2018-05-10T15:59:29.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":2133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock pursuant to Popular, Inc.'s 2004 Omnibus Incentive Plan.  The restriction of such restricted stock award lapses upon the retirement of the director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 122.79 shares acquired pursuant to reinvestment of dividends paid by the Corporation and which are exempt under Section 16 of the Securities Exchange Act."}],"balance_after":12828.433,"source":{"system":"sec-edgar","filing":"0001209191-18-029101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/763901/000120919118029101/doc4.xml","form_type":"4"}},{"id":4067470,"issuer":{"id":1363,"kind":"organization","name":"POPULAR, INC.","symbol":"BPOP"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Par Value $0.01 per share","published_at":"2018-02-12T21:38:14.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":120.643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to reinvestment of dividends paid by the Corporation and which are exempt under Section 16 of the Securities Exchange Act."}],"balance_after":10572.643,"source":{"system":"sec-edgar","filing":"0001209191-18-009222","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/763901/000120919118009222/doc5.xml","form_type":"5"}},{"id":4307483,"issuer":{"id":1363,"kind":"organization","name":"POPULAR, INC.","symbol":"BPOP"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Par Value $0.01 per share","published_at":"2017-05-24T17:29:46.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":2343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock pursuant to Popular, Inc.'s 2004 Omnibus Incentive Plan.  The restriction of such restricted stock award lapses upon the retirement of the director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 69.935 shares acquired pursuant to reinvestment of dividends paid by the Corporation and which are exempt under Section 16 of the Securities Exchange Act."}],"balance_after":10452,"source":{"system":"sec-edgar","filing":"0001209191-17-034853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/763901/000120919117034853/doc4.xml","form_type":"4"}},{"id":4456110,"issuer":{"id":1363,"kind":"organization","name":"POPULAR, INC.","symbol":"BPOP"},"owners":[{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":1,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Par Value $0.01 per share","published_at":"2017-02-13T12:08:22.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":66.202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to reinvestment of dividends paid by the Corporation and which are exempt under Section 16 of the Securities Exchange Act."}],"balance_after":8039.064,"source":{"system":"sec-edgar","filing":"0001209191-17-009816","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/763901/000120919117009816/doc5.xml","form_type":"5"}}]}